Company

TFC Therapeutics, Inc.

TFC Therapeutics develops biologic drugs for cancer treatment and recurrence prevention.

About

TFC Therapeutics is developing biologics that target tumor macrophage hybrid cells associated with cancer recurrence and metastasis. Founded in 2022, the company is based in New York, US. It raised venture funding led by ARCH Venture Partners in August 2023.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in